We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Why Punch Taverns plc (LON: PUB), Greene King plc (LON: GNK) and Dechra Pharmaceuticals plc Should Beat The FTSE 100 Today

Punch Taverns plc (LON: PUB), Greene King plc (LON: GNK) and Dechra Pharmaceuticals plc (LON: DPH) are on the up.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The FTSE 100 (FTSEINDICES: ^FTSE) was briefly in positive territory this morning, before turning tail and shedding 23 points to 6,484 by mid-morning.

The big news from Vodafone didn’t provide the boost some might have expected, as shares in the telecom giant fell back a little this morning. And there was very little action elsewhere in the top London index — even the miners are showing a muted reaction to reports of rising Chinese demand.

Should you buy Dechra Pharmaceuticals Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

But which shares are doing well today? Here are three names that are responding to good news and look set to beat the market today:

Punch Taverns

A full-year trading update gave Punch Taverns (LSE: PUB) shares a boost this morning, taking them up 6% to 13p.

The pub operator told us that average net income per pub was up 1.5% over the year, and though like-for-like net income was down over the year, it had pushed upwards in the final quarter. The firm had let 96% of its core pubs by the end of the year, slightly up on 94% a year previously, and has disposed of 433 pubs over the year for a total of £149m which was better than book value.

Executive chairman Stephen Billingham said: “We reiterate our previous expectations of net income growth in the core estate for the years ahead”, though analysts are still forecasting a further fall in annual profits next year.

Greene King

Boozers are in the news today, as shares in Greene King (LSE: GNK) gained 12.5p (1.5%) in early trading to 860p, and though the gain had dropped to just 1p by the time of writing, it’s still in with a shout of beating the FTSE today.

This time the driver was an interim update, telling us of a 4.6% like-for-like sales gain in the firm’s Retail division, with like-for-like Food sales up 5.7% and Accommodation up 6%.

The company told us: “There appear to be cautious signs of optimism in terms of recent UK macro-economic improvements. In turn, we are seeing indications of growing consumer confidence, which is reflected in our strong start to the financial year“, and said it expects to deliver “sustained earnings growth and attractive dividends“.

Dechra Pharmaceuticals

Full-year results gave Dechra Pharmaceuticals (LSE: DPH) a modest boost, taking the shares up 6p (1%) to 696p by mid-morning — they’re now up 40% over the past 12 months, though they were higher earlier in the year.

Following a year of restructuring, chief executive Ian Page said: “Dechra is now entirely focused on developing, manufacturing and marketing high margin, cash generative specialist veterinary pharmaceuticals and related products for global markets“.

So how did the numbers come out?

After a number of disposals, revenue from continuing operations rose by 52% to £189m, though revenue from discontinued operations amounted to £332m — total revenue rose by 19%. Underlying pre-tax profit from continuing operations gained 54% to £33.5m, with overall profit up 15%. Underlying earnings per share rose by 20% to 38.7p, and the dividend was lifted 14% to 14p per share.

Finally, if you’re looking for investments that should take you all the way to a comfortable retirement, I recommend the Fool’s special new report detailing five blue-chip shares. They’ll be familiar names to many, and they’ve already provided investors with decades of profits.

But the report will only be available for a limited period, so click here to get your hands on these great ideas — they could set you on the road to long-term riches.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in Vodafone.

More on Investing Articles

Overjoyed exited middle aged married couple giving high five, finishing doing domestic paperwork together at home. Euphoric happy older mature spouses celebrating successful investment or purchase.
Investing Articles

This beaten-down FTSE 100 dividend share just jumped 11% in a week but still yields almost 5%

Harvey Jones has been highlighting this dividend share opportunity for weeks and suddenly it's showing signs of life. Can the…

Read more »

Investing Articles

Down 53% since May, is this SpaceX-backed UK stock now in the bargain bin?

The Filtronic (LSE:FTC) share price has come crashing back down to earth in recent weeks. Has the selling gone too…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

3,566 shares in this FTSE 100 stalwart earns a £1,443 second income

Stephen Wright sees Unilever's battered share price as an attractive option for investors looking for a second income to consider.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

3 stocks I’m looking to buy in July

Stephen Wright’s stocks to buy list for July includes a specialist chemicals recovery play, a quiet infrastructure compounder, and an…

Read more »

ISA Individual Savings Account
Investing Articles

How do the government’s latest changes affect your Stocks and Shares ISA?

Stephen Wright explains what the new anti-circumvention rules mean for investors with uninvested cash in their Stocks and Shares ISAs.

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

Here’s how much I think Rolls-Royce shares will be worth by the end of 2027

Ken Hall is considering buying Rolls-Royce shares. But just how much further could the stock climb by the end of…

Read more »

Young woman holding up three fingers
Investing Articles

Looking for cheap stocks to buy under £1? Here are 3 quality UK businesses to consider

Always on the hunt for cheap stocks to buy, our writer identifies three appealing UK candidates with strong financials and…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Investing Articles

Could small modular reactors take Rolls-Royce shares to the next level?

Rolls-Royce Holdings is investing heavily in the development of mini nuclear power stations. But what could this mean for the…

Read more »